POSIMIR Trademark

Trademark Overview

On Wednesday, November 21, 2012, a trademark application was filed for POSIMIR with the United States Patent and Trademark Office. The USPTO has given the POSIMIR trademark a serial number of 85785555. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, July 30, 2022. This trademark is owned by DURECT CORPORATION. The POSIMIR trademark is filed in the Pharmaceutical Products category with the following description:

Surgical, medical, dental and veterinary materials, namely, pharmaceuticals and preparations for the relief of pain, namely, topical, injectable and implantable compositions of analgesic and anesthetic agents to provide local and regional prevention of and/or relief from pain
posimir

General Information

Serial Number85785555
Word MarkPOSIMIR
Filing DateWednesday, November 21, 2012
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, July 30, 2022
Registration Number4918452
Registration DateTuesday, March 15, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2013

Trademark Statements

Goods and ServicesSurgical, medical, dental and veterinary materials, namely, pharmaceuticals and preparations for the relief of pain, namely, topical, injectable and implantable compositions of analgesic and anesthetic agents to provide local and regional prevention of and/or relief from pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 1, 2012
Primary Code005
First Use Anywhere DateThursday, November 12, 2015
First Use In Commerce DateThursday, November 12, 2015

Trademark Owner History

Party NameDURECT CORPORATION
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCupertino, CA 95014
Party NameINNOCOLL PHARMACEUTICALS LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDUBLIN 2 D02 R296
IE
Party NameDURECT CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCupertino, CA 95014
Party NameDURECT CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCupertino, CA 95014
Party NameDURECT CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCupertino, CA 95014

Trademark Events

Event DateEvent Description
Saturday, December 1, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 24, 2012NEW APPLICATION ENTERED
Thursday, March 14, 2013ASSIGNED TO EXAMINER
Thursday, November 21, 2013SOU EXTENSION 1 FILED
Friday, March 15, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2013PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 24, 2013NOTICE OF PUBLICATION
Tuesday, June 18, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 21, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 21, 2013SOU TEAS EXTENSION RECEIVED
Thursday, November 21, 2013SOU EXTENSION 1 GRANTED
Saturday, November 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 24, 2014SOU TEAS EXTENSION RECEIVED
Monday, November 24, 2014SOU EXTENSION 3 FILED
Monday, December 22, 2014SOU EXTENSION 3 GRANTED
Tuesday, June 17, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, June 17, 2014SOU EXTENSION 2 FILED
Monday, July 21, 2014SOU EXTENSION 2 GRANTED
Monday, July 14, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 22, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 26, 2016SOU EXTENSION 5 GRANTED
Tuesday, December 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 20, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, May 20, 2015SOU EXTENSION 4 FILED
Monday, May 25, 2015SOU EXTENSION 4 GRANTED
Tuesday, May 26, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 11, 2015TEAS STATEMENT OF USE RECEIVED
Friday, December 11, 2015SOU TEAS EXTENSION RECEIVED
Friday, December 11, 2015USE AMENDMENT FILED
Friday, December 11, 2015SOU EXTENSION 5 FILED
Wednesday, February 16, 2022TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 26, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 5, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, February 6, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 15, 2016REGISTERED-PRINCIPAL REGISTER
Monday, March 15, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, July 30, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, July 30, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 23, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 23, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 23, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 23, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 23, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 10, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 9, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, July 30, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, March 15, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

posimir pain relief namely from anesthetic analgesic prevention agents local compositions